Salveen Richter, Goldman Sachs lead biotech analyst, joins 'Squawk Box' to discuss the troubles facing Sarepta and its ...

For one, Goldman CEO David Solomon doesn’t like overpaying, which is exactly what he’d have to do at this point to get ...

Goldman Sachs and BNP Paribas scrapped their forecasts for a September rate cut by the European Central Bank, now expecting ...

Goldman Sachs analysts are sounding the alarm on speculative trades. They could be signaling a market pullback ahead.

For all the sci-fi promises about blockchain transforming finance, the reality will be more mundane as thousands of ordinary ...

Goldman Sachs said in a note Friday that its Speculative Trading Indicator has surged to historic levels, reaching its highest reading outside of the dot-com and pandemic-era bubbles.

Bursts of euphoric trading are often bullish for near-term returns, but rapid surges in speculation also raise the risk of a ...

Goldman Sachs is warning of a possible stock market correction, thanks to high risk-appetite and enthusiastic retail ...

Bank of New York Mellon Corp. and Goldman Sachs Group Inc. are collaborating to use blockchain technology to maintain an ...

Amkor Technology Inc. (NASDAQ: AMKR) is one of the most oversold semiconductor stocks so far in 2025. On July 10, Goldman ...

Financial giant Goldman Sachs has acquired a controlling stake in Mace Consult, the consultancy arm of UK-headquartered ...

Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best biotech stocks to buy according to billionaire Steve Cohen.